Clinical Trial Update: Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical sirolimus ointment for cutaneous angiofibromas in tuberous sclerosis complex subjects was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis Complex

Drugs mentioned

• Topical sirolimus ointment (sirolimus)

Snippet

Sponsor: Aucta Pharmaceuticals, Inc | Conditions: Angiofibroma of Face, Tuberous Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2025-12-01